| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2019-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b45c28f90c0e03662632ce4ba7c65bd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12327481669309c759a345a2e7c803df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1dfaee3dbcf2689faf39304d94d5d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4581be9d796dc3d0639839ea3d252a7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21101184ca71442baaef87050a7d3cce |
| publicationDate |
2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102001437-B1 |
| titleOfInvention |
A Pharmaceutical composition for preventing or treating of fibrosis |
| abstract |
The present invention relates to a pharmaceutical composition for the prevention or treatment of fibrosis, wherein the composition comprising the compound represented by the formula (1) as an active ingredient is used for preventing or treating fibrosis by inhibiting the expression or activity of histone acetyltransferase Can be used very effectively. Furthermore, since the compound of formula (I) of the present invention specifically inhibits only p300 among various histone acetyltransferases, it does not affect other acetylating enzymes which play an important role in life support, Or side effects that may occur during treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023059099-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021261909-A1 |
| priorityDate |
2019-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |